See analyst estimates and all valuation multiples for Health & Beauty
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $462B | 7.6x | 17.7x | |
| $388B | 4.5x | 16.3x | |
| $249B | 4.8x | 19.9x | |
| $177B | 2.6x | 11.9x | |
| $91.2B | 1.7x | 8.1x | |
| $82.8B | 4.1x | 16.8x | |
| $65.3B | 3.4x | 12.2x | |
| $59.9B | 8.4x | 36.8x | |
| $57.3B | 3.8x | 15.1x | |
| $50.3B | 3.4x | 23.6x | |
| $47.0B | 8.9x | 38.7x | |
| $42.5B | 2.8x | 12.7x | |
| $41.2B | 4.3x | 17.6x | |
| $36.6B | 1.5x | 8.3x | |
| $32.2B | 2.6x | 17.7x | |
| $25.5B | 4.1x | 18.1x | |
| $23.3B | 1.5x | 8.1x | |
| $23.2B | 2.0x | 11.4x | |
| $21.8B | 2.1x | 6.0x | |
| $18.1B | 1.7x | 11.0x | |
| $13.1B | 7.8x | 38.0x | |
| $12.9B | 2.2x | 10.8x | |
| $12.6B | 2.1x | 14.2x | |
| $10.2B | 7.4x | 41.0x | |
| $9.9B | 6.5x | 26.1x | |
| $9.4B | 6.5x | 34.9x | |
| $8.9B | 1.4x | 8.3x | |
| $8.6B | 1.4x | 13.5x | |
| $6.9B | 1.2x | 6.7x | |
| $6.8B | 6.8x | 26.5x | |
| $6.1B | 9.3x | 29.0x | |
| $5.8B | 3.8x | 19.0x | |
| $5.6B | 1.9x | 12.8x | |
| $5.2B | 1.2x | 7.2x | |
| $4.7B | 2.2x | 12.5x | |
| $4.4B | 1.5x | 6.4x | |
| $4.2B | 10.1x | 30.7x | |
| $4.2B | 8.7x | 33.9x | |
| $4.1B | 3.7x | 11.3x | |
| $4.1B | 1.2x | 6.9x | |
| $3.9B | 1.2x | 7.7x | |
| $3.6B | 2.2x | 12.1x | |
| $3.5B | 1.6x | 9.9x | |
| $3.3B | 2.2x | 10.9x | |
| $3.3B | 2.7x | 16.5x | |
| $3.2B | 0.9x | 5.9x | |
| $3.2B | 0.7x | 6.0x | |
| $3.0B | 3.5x | 8.7x | |
| $3.0B | 9.3x | 34.6x | |
| $3.0B | 1.4x | 9.8x | |
| $2.6B | 1.0x | 7.8x | |
| $2.6B | 1.1x | 5.6x | |
| $2.6B | 2.4x | 10.9x | |
| $2.3B | 2.9x | 20.6x | |
| $2.3B | 0.5x | 6.5x | |
| $2.2B | 5.3x | 19.9x | |
| $2.2B | 5.8x | 16.7x | |
| $2.2B | 3.8x | 18.7x | |
| $2.1B | 1.0x | 7.1x | |
| $2.0B | 1.2x | 10.1x | |
| $1.9B | 1.7x | 12.6x | |
| $1.9B | 2.8x | 13.1x | |
| $1.9B | 2.5x | 12.4x | |
| $1.7B | 0.9x | 7.3x | |
| $1.7B | 2.1x | 10.6x | |
| $1.7B | 6.3x | 17.7x | |
| $1.6B | 0.8x | 8.4x | |
| $1.5B | n/a | n/a | |
| $1.5B | 1.2x | 8.4x | |
| $1.4B | 1.7x | 7.3x | |
| $1.3B | 0.8x | 6.3x | |
| $1.3B | 0.6x | 5.8x | |
| $1.1B | 2.7x | 12.2x | |
| $1.1B | 1.5x | 10.3x | |
| $1.0B | 0.9x | 8.5x | |
| $955M | 1.2x | 6.5x | |
| $950M | 2.1x | 9.9x | |
| $940M | 3.8x | 55.1x | |
| $929M | 7.4x | 27.8x | |
| $818M | 0.3x | 1.8x | |
| $793M | 1.8x | 11.0x | |
| $740M | n/a | n/a | |
| $650M | n/a | n/a | |
| $642M | n/a | n/a | |
| $607M | 0.8x | 6.8x | |
| $571M | 3.3x | 13.1x | |
| $544M | 0.4x | n/a | |
| $503M | n/a | n/a | |
| $502M | 0.7x | 3.4x | |
| $416M | 1.4x | -19.7x | |
| $415M | 2.0x | -44.6x | |
| $411M | 1.5x | 18.7x | |
| $384M | n/a | n/a | |
| $346M | 1.2x | 9.3x | |
| $316M | 6.1x | 23.2x | |
| $308M | n/a | n/a | |
| $300M | n/a | n/a | |
| $268M | 0.6x | 7.4x | |
| $228M | 1.6x | 6.8x | |
| $212M | n/a | n/a | |
| $208M | 0.6x | 9.4x | |
| $198M | 0.4x | 11.5x | |
| $195M | 1.0x | 9.6x | |
| $191M | 2.3x | 13.5x | |
| $174M | 0.8x | 3.7x | |
| $155M | 0.8x | 5.6x | |
| $137M | 2.2x | 8.0x | |
| $136M | 0.6x | 5.5x | |
| $132M | 0.5x | 6.0x | |
| $124M | n/a | n/a | |
| $85.3M | n/a | n/a | |
| $70.3M | 0.3x | 7.3x | |
| $65.6M | n/a | n/a | |
| $61.0M | 2.3x | 9.7x | |
| $42.5M | n/a | n/a | |
| $40.2M | n/a | n/a | |
| $40.1M | n/a | n/a | |
| $36.6M | 0.8x | n/a | |
| $27.9M | 2.2x | n/a | |
| $25.1M | n/a | n/a | |
| $25.1M | n/a | n/a | |
| $20.6M | 1.1x | -12.0x | |
| $18.1M | n/a | n/a | |
| $13.3M | n/a | n/a | |
| $9.0M | n/a | n/a | |
| $6.9M | n/a | n/a | |
| $5.3M | n/a | n/a | |
| $1.0M | n/a | n/a | |
| -$38.8M | -0.1x | -64.7x |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Health & Beauty